Ferguson PLC Results for the 3 months ended 30 April 2019

Ferguson PLC

CONTINUED GROWTH, RE-AFFIRMING GUIDANCE, $500 MILLION SHARE BUY BACK

Ongoing businesses1US$ millionsQ3 2019Q3 2018 Change
Revenue5,2744,968+6.2%
Trading profit2359351+2.3%
Net debt to EBITDA 0.9x0.9x3

 

Third quarter highlights

−          Ongoing revenue growth of 6.2%, including 8.4% in the USA.

−          Solid gross margins, slightly ahead of last year.

−          Good cost control, underlying operating costs lower than in Q2.

−          Ongoing trading profit of $359 million was $8 million ahead of last year.

−          Strong operating cash generation of $632 million in the quarter with net debt to EBITDA of 0.9x.

−          Share buy back of $500 million announced today.

 

John Martin, Group Chief Executive, commented:

“The Group continued to grow in Q3 with revenue 6.2% ahead. We also continued to successfully grow our gross margins and have improved our underlying cost base over the last two quarters.

“We are confident that Ferguson will continue to make progress as we remain firmly focused on delivering superior customer service. We expect to generate ongoing Group trading profit in the year ended 31 July 2019 in line with current analysts’ consensus forecasts.4

“Cash generation continued to be excellent and our balance sheet remains strong. We will continue to invest organically in our businesses supplemented by bolt-on acquisitions in our core operations. Given our strong financial position, and in line with our capital allocation policy, we are initiating a $500 million share buy back programme which we expect to complete over the next 12 months.”

Share on:

Latest Company News

Genflow Biosciences reports early findings from SIRT6 gene therapy study

Genflow Biosciences reports early findings from its SIRT6 gene therapy study in older dogs, with further monitoring planned over...

Ilika CEO to discuss battery gigafactory development at Barcelona industry forum

Ilika CEO Graeme Purdy is set to speak at the December 2026 Barcelona battery gigafactory forum, bringing the company's...

Investors demand clear returns as AI spending comes under scrutiny

Investors are demanding clearer returns from AI spending as technology shares face pressure, with corporate earnings, data centre investment...

Novo Nordisk deal puts focus on next generation of oral GLP-1 treatments

Novo Nordisk secures rights to Hengrui's investigational HRS-1596 in a potential $2.6bn deal, targeting the development of once-weekly oral...

itim Group targets retail AI market with new platform launch

ITIM Group is targeting the retail AI market with itimAIQ, a new platform designed to automate operations, improve efficiency...

Drax sets date for 2026 Capital Markets Day and trading update

Drax Group will host its Capital Markets Day on 23 November 2026, providing investors and analysts with a management...

    Search